A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial
Rosati, Gerardo, Cella, Chiara Alessandra, Cavanna, Luigi, Codecà, Carla, Prisciandaro, Michele, Mosconi, Stefania, Luchena, Giovanna, Silvestris, Nicola, Bernardini, Ilaria, Casaretti, Rossana, Zoratto, Federica, Amoroso, Domenico, Ciarlo, Andrea, Barni, Sandro, Cascinu, Stefano, Davite, Cristina, Di Sanzo, Alessandro, Casolaro, Alessia, Bilancia, Domenico, Labianca, Roberto
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2022)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2022)
Get full text
Journal Article
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas
Vannata, Barbara, Vanazzi, Anna, Negri, Mara, Liptrott, Sarah Jayne, Bartosek, Anna Amalia, Miani, Monica, Di Sanzo, Alessandro, Cavalli, Franco, Zucca, Emanuele, Stathis, Anastasios
Published in Hematological oncology (01.02.2021)
Published in Hematological oncology (01.02.2021)
Get full text
Journal Article
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors
Weiss, Glen J., Jameson, Gayle, Von Hoff, Daniel D., Valsasina, Barbara, Davite, Cristina, Di Giulio, Claudia, Fiorentini, Francesco, Alzani, Rachele, Carpinelli, Patrizia, Di Sanzo, Alessandro, Galvani, Arturo, Isacchi, Antonella, Ramanathan, Ramesh K.
Published in Investigational new drugs (01.02.2018)
Published in Investigational new drugs (01.02.2018)
Get full text
Journal Article
Abstract CT074: ELECTRA: An open-label, multicenter, phase 1b/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC)
Hamilton, Erika, Kim, Sung-Bae, Lin, Nancy U., Awada, Ahmad, Gil, Eva Ciruelos, Sanzo, Alessandro Di, Vallespir, Bartomeu Piza, Theall, Kathy Puyana, Ibrahim, Nuhad
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
A Phase I/II Study of NMS-03592088, a FLT3, KIT and CSF1R Inhibitor, in Patients with Relapsed or Refractory AML or CMML
Ciomei, Marina, Zanetta, Lucia, Lussana, Federico, Ravelli, Erika, Fiorentini, Francesco, Bosotti, Roberta, Ardini, Elena, Lombardi Borgia, Andrea, Pulci, Romana, Gatto, Rosalinda, Di Sanzo, Alessandro, Colajori, Elena, Davite, Cristina, Galvani, Arturo, Gan, Frank Xiaodong, Rossi, Giuseppe, Della Porta, Matteo Giovanni, Cairoli, Roberto, Rambaldi, Alessandro, Isacchi, Antonella
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article